An Open Label, 2-treatment, 2-period, Single Sequence Study to Evaluate Pharmacokinetic Drug-drug Interaction Between Ramipril and Sotagliflozin at Steady State in Healthy Subjects
Latest Information Update: 29 Apr 2020
At a glance
- Drugs Sotagliflozin (Primary) ; Ramipril
- Indications Cardiovascular disorders; Heart failure; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 29 Mar 2018 Status changed from recruiting to completed.
- 01 Feb 2018 New trial record